Schistosomiasis in areas of low endemicity: A new era in diagnosis.

Trends in Parasitology

Volumn 29, Issue 2, 2013, Pages 75-82

  Cavalcanti, Marta G ^a   Silva, Leonardo F ^a   Peralta, Regina H S ^b   Barreto, Magali G M ^c   Peralta, José M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antigen detection; Immunodiagnosis; Low endemicity area; Schistosoma; Schistosomiasis

Indexed keywords

COPROSCOPY; DIAGNOSTIC TEST; DNA DETERMINATION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD STANDARD; HUMAN; IMMUNOREACTIVITY; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SCHISTOSOMIASIS; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES, HELMINTH; DNA, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HUMANS; POLYMERASE CHAIN REACTION; SCHISTOSOMA; SCHISTOSOMIASIS;

SCHISTOSOMA;

EID: 84872834894     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2012.11.003     Document Type: Review

References (78)

1. McCarthy J.S., et al. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl. Trop. Dis. 2012, 6:e1601.
2. Rollinson D., et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2012, 10.1016/j.actatropica.2012.04.013.
3. Gonçalves M.M., et al. Immunoassays as an auxiliary tool for the serodiagnosis of Schistosoma mansoni infection in individuals with low intensity of egg elimination. Acta Trop. 2006, 100:24-30.
4. Igreja R.P., et al. Schistosoma mansoni-related morbidity in a low-prevalence area of Brazil: a comparison between egg excretors and seropositive non-excretors. Ann. Trop. Med. Parasitol. 2007, 101:575-584.
5. Enk M.J., et al. The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmission. Acta Trop. 2008, 108:222-228.
6. Silva L.C., et al. Schistosoma mansoni: magnetic resonance analysis of liver fibrosis according to WHO patterns for ultrasound assessment of schistosomiasis-related morbidity. Mem. Inst. Oswaldo Cruz 2010, 105:467-470.
7. Ferrari T.C., Moreira P.R. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol. 2011, 10:853-864.
8. Coelho P.M., et al. Use of a saline gradient for the diagnosis of schistosomiasis. Mem. Inst. Oswaldo Cruz 2009, 104:720-723.
9. Fagundes Teixeira C., et al. Detection of Schistosoma mansoni eggs in feces through their interaction with paramagnetic beads in a magnetic field. PLoS Negl. Trop. Dis. 2007, 14:e73.
10. Wu H.W., et al. High prevalence of Schistosoma japonicum infection in water buffaloes in the Philippines asses. Am. J. Trop. Med. Hyg. 2010, 82:646-652.
11. Zhou X.N., et al. Tools to support policy decisions related to treatment strategies and surveillance of Schistosomiasis japonica towards elimination. PLoS Negl. Trop. Dis. 2011, 5:e1408.
12. Ashton R.A., et al. Accuracy of circulating cathodic antigen tests for rapid mapping of Schistosoma mansoni and S. haematobium infections in Southern Sudan. Trop. Med. Int. Health 2011, 16:1099-1103.
13. ten Hove R.J., et al. Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S. haematobium infection in stool samples collected in northern Senegal. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:179-185.
14. Lier T., et al. Real-time PCR for detection of low intensity Schistosoma japonicum infections in a pig model. Acta Trop. 2008, 105:74-80.
15. Stothard J.R., et al. An evaluation of urine-CCA strip test and fingerprick blood SEA-ELISA for detection of urinary schistosomiasis in schoolchildren in Zanzibar. Acta Trop. 2009, 111:64-70.
16. Stothard J.R., et al. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:325-332.
17. Gomes L.I., et al. Development and evaluation of a sensitive PCR-ELISA system for detection of Schistosoma infection in feces. PLoS Negl. Trop. Dis. 2010, 4:e664.
18. Oliveira L.M.A., et al. Evaluation of polymerase chain reaction as an additional tool for the diagnosis of low-intensity Schistosoma mansoni. infection. Diagn. Microbiol. Infect. Dis. 2010, 68:416-421.
19. Shane H.L., et al. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya. PLoS Negl. Trop. Dis. 2011, 5:e951.
20. Stothard J.R., et al. Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable?. PLoS Negl. Trop. Dis. 2011, 5:e938.
21. Xu J., et al. Evaluation of immunoassays for the diagnosis of Schistosoma japonicum infection using archived sera. PLoS Negl. Trop. Dis. 2011, 5:e949.
22. Xu J., et al. Performance of a dipstick dye immunoassay for rapid screening of Schistosoma japonicum infection in areas of low endemicity. Parasit. Vectors 2011, 20:87.
23. Mutapi F., et al. Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunol. 2011, 33:181-192.
24. de Oliveira E.J., et al. Synthetic peptides as an antigenic base in an ELISA for laboratory diagnosis of schistosomiasis mansoni. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:360-366.
25. Sulbarán G.S., et al. Detection of the Sm31 antigen in sera of Schistosoma mansoni- infected patients from a low endemic area. Parasite Immunol. 2010, 32:20-28.
26. Zhong Z.R., et al. Serological proteome-oriented screening and application of antigens for the diagnosis of Schistosomiasis japonica. Acta Trop. 2010, 116:1-8.
27. Alarcón de Noya B., et al. Detection of schistosomiasis cases in low-transmission areas based on coprologic and serologic criteria. The Venezuelan experience. Acta Trop. 2007, 103:41-49.
28. Ferrari T.C. A laboratory test for the diagnosis of neuroschistosomiasis. Neurol. Res. 2010, 32:252-2629.
29. Cavalcanti M.G., et al. Genital schistosomiasis mansoni concomitant to genital tumor in areas of low endemicity: challenging diagnosis. Braz. J. Infect. Dis. 2011, 15:174-177.
30. Meltzer E., et al. Schistosomiasis among travelers: new aspects of an old disease. Emerg. Infect. Dis. 2006, 12:1696-1700.
31. Nicolls D.J., et al. Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008. Am. J. Trop. Med. Hyg. 2008, 79:729-734.
32. Hotez P.J., et al. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat. Rev. Microbiol. 2010, 8:814-826.
33. Ahmad G., et al. Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J. Infect. Dis. 2011, 204:1437-1449.
34. Amarir F., et al. National serologic survey of Haematobium schistosomiasis in Morocco: evidence for elimination. Am. J. Trop. Med. Hyg. 2011, 84:15-19.
35. Noya B.A., et al. Low transmission areas of schistosomiasis in Venezuela: consequences on the diagnosis, treatment, and control. Mem. Inst. Oswaldo Cruz 2006, 101:29-35.
36. Freitas A.R., et al. Schistosomal myeloradiculopathy in a low-prevalence area: 27 cases (14 autochthonous) in Campinas, São Paulo, Brazil. Mem. Inst. Oswaldo Cruz 2010, 105:398-408.
37. Oliveira R.R., et al. Factors associated with resistance to Schistosoma mansoni infection in an endemic area of Bahia, Brazil. Am. J. Trop. Med. Hyg. 2012, 86:296-305.
38. McManus D.P., et al. Schistosomiasis research in the Dongting lake region and its impact on local and national treatment and control in China. PLoS Negl. Trop. Dis. 2011, 5:e1053.
39. Verani J.R., et al. Schistosomiasis among young children in Usoma, Kenya. Am. J. Trop. Med. Hyg. 2011, 84:787-791.
40. Chunge C.N., et al. An outbreak of acute schistosomiasis following a church retreat to Mwanza, Tanzania, 2008. J. Travel Med. 2011, 18:408-410.
41. Lin D.D., et al. Evaluation of IgG-ELISA for the diagnosis of Schistosoma japonicum in a high prevalence, low intensity endemic area of China. Acta Trop. 2008, 107:128-133.
42. Zhou Y.B., et al. A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control. Parasit. Vectors 2011, 4:194.
43. Beck L., et al. Discriminating acute from chronic human schistosomiasis mansoni. Acta Trop. 2008, 108:229-233.
44. Caldas I.R., et al. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop. 2008, 108:109-117.
45. Pereira W.R., et al. Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk. Acta Trop. 2010, 113:34-41.
46. Vereecken K., et al. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni. Trop. Med. Int. Health 2007, 12:431-444.
47. Tweyongyere R., et al. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial. BMC Infect. Dis. 2009, 18:32.
48. Souza A.L., et al. Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation. Infect. Immun. 2011, 79:1741-1749.
49. Fairfax K.C., et al. IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease. PLoS Pathog. 2012, 8:e1002490.
50. King C.H., et al. Transmission control for schistosomiasis - why it matters now. Trends Parasitol. 2006, 22:575-582.
51. Bligh J., et al. Serological analysis of the outcome of treatment of Schistosoma mansoni infections with praziquantel. Ann. Trop. Med. Parasitol. 2010, 104:511-520.
52. Coulibaly J.T., et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d'Ivoire. PLoS Negl. Trop. Dis. 2011, 5:e1384.
53. Obeng B.B., et al. Application of a circulating-cathodic-antigen (CCA) strip test and real-time PCR, in comparison with microscopy, for the detection of Schistosoma haematobium in urine samples from Ghana. Ann. Trop. Med. Parasitol. 2008, 102:625-633.
54. Lu Y., et al. Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients. Parasit. Vectors 2012, 11:115.
55. Stothard J.R., et al. Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop. 2006, 97:219-228.
56. Legesse M., Erko B. Field-based evaluation of a reagent strip test for diagnosis of schistosomiasis mansoni by detecting circulating cathodic antigen (CCA) in urine in low endemic area in Ethiopia. Parasite 2008, 15:151-155.
57. Lei J.H., et al. Evaluation of an IgY-based immunomagnetic enzyme-linked immunosorbent assay system for detection of circulating Schistosoma japonicum antigen in serum samples from patients in China. Am. J. Trop. Med. Hyg. 2011, 85:1054-1059.
58. Tchuem Tchuenté L.A., et al. Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon. PLoS Negl. Trop. 2012, 6:e1758.
59. Ayele B., et al. Evaluation of circulating cathodic antigen (CCA) strip for diagnosis of urinary schistosomiasis in Hassoba school children, Afar, Ethiopia. Parasite 2008, 15:69-75.
60. Koukounari A., et al. Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Am. J. Trop. Med. Hyg. 2009, 80:435-441.
61. Gentile R., et al. Evaluation of immunological, parasitological and molecular methods for the diagnosis of Schistosoma mansoni infection before and after chemotherapy treatment with praziquantel in experimentally infected Nectomys squamipes. Vet. Parasitol. 2011, 180:243-249.
62. Ibironke O., et al. Validation of a new test for Schistosoma haematobium based on detection of Dra1 DNA fragments in urine: evaluation through latent class analysis. PLoS Negl. Trop. Dis. 2012, 6:e1464.
63. Sandoval N., et al. Schistosoma mansoni: a diagnostic approach to detect acute schistosomiasis infection in a murine model by PCR. Exp. Parasitol. 2006, 114:84-88.
64. Kato-Hayashi N., et al. Identification and differentiation of human schistosomes by polymerase chain reaction. Exp. Parasitol. 2010, 124:325-329.
65. Kjetland E.F., et al. Schistosomiasis PCR in vaginal lavage as an indicator of genital Schistosoma haematobium infection in rural Zimbabwean women. Am. J. Trop. Med. Hyg. 2009, 81:1050-1055.
66. Wichmann D., et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl. Trop. Dis. 2009, 6:e1464.
67. Wang C., et al. Application of DNA-based diagnostics in detection of schistosomal DNA in early infection and after drug treatment. Parasit. Vectors 2011, 24:164.
68. Njiru Z.K. Loop-mediated isothermal amplification technology: towards point of care diagnostics. PLoS Negl. Trop. Dis. 2012, 6:e1572.
69. Enk M.J., et al. Diagnostic accuracy and applicability of a PCR System for the detection of Schistosoma mansoni DNA in human urine samples from an endemic area. PLoS Negl. Trop. Dis. 2012, 7:e38947.
70. Allam A.F., et al. Assessing the marginal error in diagnosis and cure of Schistosoma mansoni in areas of low endemicity using Percoll and PCR techniques. Trop. Med. Int. Health 2009, 14:316-321.
71. Imai N., et al. Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria. Parasitology 2011, 138:1519-1533.
72. Pinot de Moira A., et al. Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE. PLoS Negl. Trop. Dis. 2010, 4:e820.
73. Mitchell K.M., et al. Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:13347-13352.
74. Dunne D.W., et al. Human antibody responses to Schistosoma mansoni: does antigen directed, isotype restriction result in the production of blocking antibodies?. Mem. Inst. Oswaldo Cruz 1987, 82(Suppl. 4):101-104.
75. Hagan P., et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991, 349:243-245.
76. Jiz M., et al. Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. Infect. Immun. 2009, 77:2051-2058.
77. McManus D.P., et al. Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. Clin. Microbiol. Rev. 2010, 23:442-466.
78. Bonnard P., et al. Specific isotype immune response in the diagnosis of human schistosomiasis pathology?. Am. J. Trop. Med. Hyg. 2004, 71:202-205.